Health
NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells – News-Medical.Net
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and…

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
The findings were published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. These results led to…
-
Noosa News22 hours ago
Ensure voices are heard – Proctor
-
Noosa News24 hours ago
City of Moreton Bay claims homeless people consented to having camps thrown away
-
Business23 hours ago
ASX ETFs to target amidst an ageing population
-
Noosa News18 hours ago
Major crash on Gateway Motorway snarls morning commute